Skip to content
Oversubscribed Private Placement of €1.42 Million

Press release -

Oversubscribed Private Placement of €1.42 Million

The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. The share issue was oversubscribed and provided the company with 12 new shareholders. Gross proceeds from the private placement amounted to NOK 11,550,000 (€1.42 Million)

- We are pleased to note the considerable interest in the recently concluded placement in ConceptoMed AS, says CEO Christian Mide.

- In addition to many of the existing shareholders having made use of the opportunity to increase their share of the company, 12 new shareholders have been added to the owner base, says Chairman Sverre Christoffersen. The new shareholders provide the company with a strong owner base with relevant background - which will be involved in lifting the company's activities in future efforts.

ConceptoMed AS has already met considerable interest in the market, and stands before an exciting international development of both Luer-Jack ™ and ConceptoShield ™.

The share issue values ConceptoMed AS at NOK 86.5 million (€10.6 Million).

Subjects

Categories



Press contacts

Christian Mide

Christian Mide

Press contact CEO +47 95 100720

Related content

Tribute to Simplicity!

ConceptoMed AS is an ambitious medtech company serving the global market with innovative product categories and unique proprietary technology. We create smart medtech systems that empower smart healthcare professionals and improve patient care. Excellence through simplicity is our code. We are brave, curious and dedicated. We simply care. For more information on the company, see www.conceptomed.com - Follow us on MyNewsdesk and LinkedIn.

The ConceptoMed technology is widely patent protected throughout the world, currently with almost 70 patents (granted and pending) from almost 20 patent families.

ConceptoMed
Hattvikveien 2
8373 Ballstad
Norway